Home Search
breast cancer - search results
If you're not happy with the results, please do another search
Stem cells and personalised therapies for cancer
Professor Alan Clarke, Director of the European Cancer Stem Cell Research Institute at Cardiff University, outlines the aim to develop more personalised therapies for patients with cancer and how targeting the cancer stem cell could be crucial in this development.
Cancer remains the second largest cause of death in the western...
The cancer challenge
Commissioner for Health, Tonio Borg supports Europe’s concerns about cancer and the huge challenges it presents.
Cancer continues to present a huge challenge for patients and their families, for health policy and for health services across the European Union and indeed beyond.
This is a challenge that can only grow bigger...
The future of vascular imaging technology
Researchers from Kyoto University Hospital and Preemptive Medicine and Lifestyle Related Disease Research Center, describe the future of vascular imaging technology, including how photoacoustic imaging targets tumour vessels in breast cancer.
Michael G DeGroote Institute for Pain Research and Care
The Michael G. DeGroote Institute for Pain Research and Care seeks to improve the quality of life for those living with Chronic Pain.
Are over-the-counter drugs an under-appreciated toxic danger?
OTC drugs are not harmless. Understanding the effects and dangers of OCT abuse and misuse is key to public safety, here UC Davis explains
Why are postmenopausal women more at risk of high blood pressure?
It may surprise you to know that 60% of women over the age of 65 have high blood pressure. So why are postmenopausal women more at risk of high blood pressure? Let's find out.
Personalized medicine: “Tyranny of the gene”
Dr Priya Hays, Ph.D., CEO/Science Writer at Hays Documentation Specialists, LLC, responds to “Tyranny of the Gene.” Is personalized medicine a threat to public health? Not really, but yes, it’s an argument for price controls and perhaps more regulations; we hear.
Mesothelioma: The unravelling of a perplexing puzzle
Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, explores the key challenges in mesothelioma prevention, diagnosis and treatment.
Walking for health: Impact of living in walkable neighborhoods
Living in walkable neighbourhoods can significantly lower the risk of obesity-related cancers in women, says a new study from Columbia University.
How can AI oncology diagnostics help the NHS?
DeepMed has developed an AI oncology diagnostics system, DeepPathTM - LYDIA, to assist histopathologists in performing lymph node metastasis detection quickly and accurately.
Investigating OTC drugs: Are over-the-counter drugs an under-appreciated toxic danger?
Contrary to popular belief, OTC drugs are not harmless. Understanding the effects and dangers of OCT abuse and misuse is key to public safety, here UC Davis provides everything you need to know.
The emergence of precision medicine for oncology
Dr Priya Hays, PhD, considers how the rapid development of precision medicine for oncology has impacted diagnosis, treatment, and clinical outcomes in cancer care.
IC2PERMED: Fostering collaboration between Europe and China to enhance personalised medicine
Tailoring care to meet patients’ needs can dramatically improve clinical outcomes; we hear how the IC2PerMed project is bolstering efforts in personalised medicine.
Professor Richard J. Santen MD – University of Virginia Health System
Dr. Richard Santen, a Professor of Medicine in the Division of Endocrinology at the University of Virginia, maintains an active medical practice with recognition nationally as an outstanding clinical Endocrinologist
He has held several academic positions including Chief of the Division of Endocrinology and Vice Chair of Medicine at the...
Plans to make a ‘single source’ of data between NHS and private healthcare
NHS England has plans to merge data with private healthcare institutions to process and share information on healthcare activity.
What are the cardiovascular risks of hormone therapy?
Individuals suffering from gender dysphoria may decide to take hormone therapy, but a new study says that this treatment can increase the risk of serious cardiac events.
Exploring the human epidermal growth factor receptor 2 (HER2)
Gail Dianne Lewis, the Senior Principal Scientist at Discovery Oncology Genentech, Inc. analyses the human epidermal growth factor receptor 2.
Whole-person integrative oncology – A path to improved outcomes and patient empowerment
Integrative oncology gives patients the tools to not only make the environment as inhospitable to cancer as possible – it also empowers patients to take some control back after receiving a cancer diagnosis.
Terri Crudup – IQVIA
Terri Crudup is an integrative oncology researcher, author, and patient advocate. As a two-time breast cancer survivor, she brings a unique perspective to her research and advocacy
Her passion is raising awareness, access, and funding of integrative oncology therapies to provide cancer patients better quality of life and improved survival...
AI for mammography performance and quality enhancement
Lisa Johnston, PhD, Product Expert at Volpara Health, explains the use of AI for mammography performance and quality enhancement.